Yanling Zhang

Yanling Zhang

Auto-generated profile, based on publicly available information

Yanling Zhang

Department of Gastrointestinal Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan Province, China; Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Chengdu, Sichuan Province, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Genes & Diseases
Verified
Journal Article
Open access
ZLZhengyi Liu
Zhengyi Liu
CJChenxing Jian
Chenxing Jian
WYWenzheng Yuan
Wenzheng Yuan
GJGuiqing Jia
Guiqing Jia
DCDonghui Cheng
Donghui Cheng
GZGaoping Zhao
Gaoping Zhao

21 January 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
YLYanzhuo Liu
Yanzhuo Liu
QFQiang Fu
Qiang Fu
MYMaozhu Yang
Maozhu Yang
JXJianli Xu
Jianli Xu
ZZZili Zhou
Zili Zhou
GZGaoping Zhao
Gaoping Zhao
Regulatory T cells (Tregs) has been shown to be involved in the induction of transplantation tolerance in numerous models. Our previous work demonstrated that METTL14 loss impaired Treg function and hindered the establishment of transplantation tolerance. However, the underlying mechanisms remain unclear. In this study, we found that METTL14 knockdown in Tregs significantly impaired their regulatory function, leading to poor allograft function and accelerated transplant rejection. Through MeRIP and mRNA sequencing approaches, we discovered that METTL14 deficiency fostered the expression of Sema4D mRNA, a key semaphorin family member with immunoregulatory activity. Methylation of target adenosines reduced Sema4D mRNA degradation, a process mediated by the METTL14-YTHDF2 axis. Inhibition of Sema4D suppressed its interaction with its receptor, thereby preserving Treg immunoregulation capability and prolonging allograft survival through the PAK-STAT5 signaling pathway. Importantly, Sema4D expression in kidney transplant biopsies were negatively correlated with renal allograft survival. In summary, our findings suggest that METTL14 deficiency in Tregs leads to transplant rejection and reveal for the first time that Sema4D may serve as a potential therapeutic target to enhance Treg function in transplantation.

20 October 2022 in Leukemia Research
Verified
Journal Article
Closed access
YZY. Zhao
Y. Zhao
SHS. Huang
S. Huang
YJY. Jia
Y. Jia
YDY. Duan
Y. Duan
LJL. Jin
L. Jin
YZY. Zhang
Y. Zhang

6 August 2024 in Research Square
Verified
Preprint
Open access
PDF file
YZYanling Zhang
Yanling Zhang
XJXiaomei Jiang
Xiaomei Jiang
DWDongsong Wu
Dongsong Wu
HHHao Huang
Hao Huang
GJGuiqing Jia
Guiqing Jia
GZGaoping Zhao
Gaoping Zhao
The glucose transporter 2 (GLUT2) is constitutively expressed in pancreatic beta cells and hepatocytes in mice. It is the most important receptor in glucose-stimulated insulin release and hepatic glucose transport. The Sema4D is a signaling receptor on cell membranes. The correlation between Sema4D and GLUT2 has not been reported previously. We investigated whether knockdown of Sema4D could exert a hypoglycemic effect based on the increased GLUT2 expression in Sema4D -/- mice hepatocytes. First, Sema4D -/- male mice exhibited significantly greater glucose tolerance than wild-type mice in a hyperglycemic environment. Secondly, Sema4D -/- mice had more retained GLUT2 in liver membranes after streptozotocin (STZ) injection according to an immunofluorescence assay. After STZ injection, Sema4D -/- male mice did not exhibit fasting hyperinsulinemia like wild-type mice. Finally, analysis of metabolomic and immunohistochemical data also revealed that Sema4D -/- mice produce hypoglycemic effects by enhancing the pentose phosphate pathway, but not glycogen synthesis. Thus, Sema4D may play an important role in the regulation of glucose homeostasis by affecting GLUT2 synthesis.